What is B-Secur?
B-Secur is a pioneering company dedicated to enhancing cardiac care through its advanced HeartKey solutions. The company's flagship product, HeartKey Rhythm, is an FDA-cleared universal ECG analytics software designed for precise rhythm detection and analysis in cardiac monitoring. B-Secur's technology supports both cloud-based and on-device applications, delivering high clinical accuracy and operational efficiency. By providing actionable wellness insights, B-Secur aims to empower healthcare providers with improved data and analysis, fostering a more proactive approach to cardiac health management.
How much funding has B-Secur raised?
B-Secur has raised a total of $25.7M across 4 funding rounds:
Other Financing Round
$3.9M
Angel/Seed
$4.6M
Unspecified
$5.3M
Other Financing Round
$12M
Other Financing Round (2015): $3.9M with participation from Rudolf Wolff
Angel/Seed (2017): $4.6M led by Woodford Investment Management, Accelerated Digital Ventures, Kernel Capital, and British Business Bank
Unspecified (2019): $5.3M supported by Accelerated Digital Ventures and Kernel Capital
Other Financing Round (2021): $12M featuring First Capital Ventures
Key Investors in B-Secur
First Capital Ventures
First Capital Ventures is an investment group with a specialization in healthcare and related technologies, focusing on digital health and wellness platforms. They leverage a network of accredited investors to facilitate individualized investment opportunities.
Accelerated Digital Ventures
Accelerated Digital Ventures Ltd operates within the Custom Software & IT Services industry, providing support for technology-driven companies. They are known for investing in businesses with high growth potential.
Kernel Capital
Kernel Capital is a venture capital and private equity firm that invests in growth and early-stage companies, offering both capital and strategic guidance to support scaling and successful exits, particularly in technology and innovation sectors.
What's next for B-Secur?
The recent major strategic investment positions B-Secur for accelerated growth and further development of its innovative heart health technologies. With a strong foundation in EKG interpretation and analytics, the company is poised to expand its market reach and enhance its product offerings. This capital infusion will likely fuel research and development, bolster sales and marketing efforts, and potentially explore new strategic partnerships to broaden the application of HeartKey solutions across the healthcare ecosystem. B-Secur's focus on improving proactive cardiac care suggests a future where advanced diagnostics are more accessible and integrated into routine wellness.
See full B-Secur company page
